Molecular Pharmaceutics

ISSN: 1543-8384• JCR: MOL PHARMACEUTAmerican Chemical SocietyUnited States
Visit Journal Homepage
4.5
2025 Impact Factor
4.7
5-Year Impact Factor
Q1
JCR Quartile
B2
CAS Block

Molecular Pharmaceutics impact factor and JCR quartile

The 2025 impact factor for Molecular Pharmaceutics is 4.5. The 5-year impact factor is 4.7. The journal is listed as JCR Q1 in the current Journal Metrics dataset.

Use this record to check the journal title, ISSN, JCR quartile, CAS block, publisher details, and similar journals before comparing publication venues.

If you searched for Molecular Pharmaceutics impact factor 2025, compare this exact title record with the journal homepage and nearby journals in the same field. That helps avoid mixing this journal with a similarly named title, abbreviation, society series, or outdated metric snippet.

2025 impact factor and source check

This page is designed for exact-title searches such as Molecular Pharmaceutics impact factor 2025. First confirm that the ISSN and title match this record before using the metric in a journal shortlist or submission decision.

For high-stakes submission decisions, verify the title against the publisher record at the journal homepage, Clarivate's Master Journal List or Journal Citation Reports if you have access, and the context in our methodology. Treat the 5-year impact factor, JCR quartile, article volume, and similar journals as supporting context rather than a single-number publication decision.

Ranking position in Oncology

Ranked #261 in Oncology by impact factor and #256 among Q1 Oncology journals. This context helps compare Molecular Pharmaceutics against journals publishing in the same field.

#261
of 1,180 field journals

Molecular Pharmaceutics publication trend

Published 2,335 papers across the last 5 recorded years with a current impact factor of 4.5.

2026 vs 2025: -490
How Journal Metrics uses article volume

Considering submitting to Molecular Pharmaceutics?

See if your manuscript fits this journal's recent focus before you commit to a shortlist.

Match my manuscript →

Journal Details

Total Articles
8,005
H-Index
180
Open Access
Hybrid
Subject Areas
Molecular BiologyBiomaterialsPharmaceutical ScienceOncologyBiomedical Engineering

Article Volume

2021
382
2022
467
2023
517
2024
549
2025
646
2026
156
Back to Search